Olema Pharmaceuticals inc
OLMAHealthcare|Biotechnology|USA
$11.91
-0.38 (-3.09%)
Tangible Book
$5.50
Earnings Power
$4.80
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (76)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mitchell Shawnte | CHIEF LEGAL OFFICER | 2026-03-04 | SELL | 40,000 | $23.79 | $951.6K |
| Harmon Cyrus | Director | 2026-01-20 | SELL | 10,000 | $26.88 | $268.8K |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | 2026-01-15 | SELL | 103,822 | $28.7 | $2979.7K |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | 2026-01-14 | SELL | 110,000 | $28.25 | $3107.5K |
| Harmon Cyrus | Director | 2026-01-14 | SELL | 3,489 | $29.12 | $101.6K |
| Zojwalla Naseem | Chief Medical Officer | 2025-12-23 | SELL | 269,509 | $27.94 | $7530.1K |
| Harmon Cyrus | Director | 2025-12-22 | SELL | 2,881 | $28.53 | $82.2K |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | 2025-12-19 | SELL | 51,000 | $30.46 | $1553.5K |
| Harmon Cyrus | Director | 2025-09-18 | SELL | 25,000 | $8.19 | $204.8K |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | 2025-01-08 | BUY | 300,000 | $5.76 | $1728K |
| Graham G. Walmsley | Director | 2024-12-17 | SELL | 700,761 | $6.75 | $4730.1K |
| Graham G. Walmsley | Director | 2024-12-13 | SELL | 700,761 | $6.75 | $4730.1K |
| Graham G. Walmsley | Director | 2024-12-13 | BUY | 700,761 | $6.75 | $4730.1K |
| Harmon Cyrus | Director | 2024-12-11 | SELL | 16,393 | $9.03 | $148K |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | 2024-12-11 | SELL | 26,066 | $9.01 | $234.9K |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | 2024-12-11 | SELL | 27,805 | $9.01 | $250.5K |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | 2024-12-11 | SELL | 35,159 | $9.01 | $316.8K |
| Bohen Sean | PRESIDENT AND CEO | 2024-12-11 | SELL | 109,502 | $9.01 | $986.6K |
| Paradigm Biocapital Advisors LP | 10% Owner | 2024-08-01 | SELL | 2,400,000 | $14.92 | $35808K |
| Harmon Cyrus | Director | 2024-07-30 | SELL | 5,000 | $15.57 | $77.9K |
| Harmon Cyrus | Director | 2024-07-11 | SELL | 5,000 | $12.26 | $61.3K |
| Harmon Cyrus | Director | 2024-06-28 | SELL | 20,000 | $10.77 | $215.4K |
| Graham G. Walmsley | Director | 2024-06-04 | SELL | 1,175,000 | $14.85 | $17448.8K |
| Harmon Cyrus | Director | 2024-06-04 | SELL | 25,000 | $10.3 | $257.5K |
| Graham G. Walmsley | Director | 2024-06-04 | SELL | 1,175,000 | $14.85 | $17448.8K |
| Harmon Cyrus | Director | 2024-05-06 | SELL | 5,000 | $10.92 | $54.6K |
| Harmon Cyrus | Director | 2024-04-30 | SELL | 15,000 | $9.51 | $142.7K |
| Harmon Cyrus | Director | 2024-03-28 | SELL | 20,000 | $10.97 | $219.4K |
| Harmon Cyrus | Director | 2024-02-29 | SELL | 25,000 | $12.41 | $310.3K |
| Harmon Cyrus | Director | 2024-02-01 | SELL | 30,000 | $12.79 | $383.7K |
| Harmon Cyrus | Director | 2023-12-29 | SELL | 25,000 | $13.38 | $334.5K |
| Paradigm Biocapital Advisors LP | 10% Owner | 2023-12-06 | BUY | 100,000 | $11.6 | $1160K |
| Graham G. Walmsley | Director | 2023-12-05 | BUY | 640,000 | $10.74 | $6873.6K |
| Harmon Cyrus | Director | 2023-11-30 | SELL | 25,000 | $12.57 | $314.3K |
| Harmon Cyrus | Director | 2023-11-22 | SELL | 8,181 | $14.39 | $117.7K |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | 2023-11-22 | SELL | 14,556 | $14.38 | $209.3K |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | 2023-11-22 | SELL | 13,629 | $14.4 | $196.3K |
| Bohen Sean | PRESIDENT AND CEO | 2023-11-22 | SELL | 57,225 | $14.4 | $824K |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | 2023-11-22 | SELL | 18,742 | $14.39 | $269.7K |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | 2023-11-08 | SELL | 200 | $17.61 | $3.5K |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | 2023-11-03 | SELL | 10,541 | $15.26 | $160.9K |
| Harmon Cyrus | Director | 2023-11-02 | SELL | 30,000 | $12.65 | $379.5K |
| Harmon Cyrus | Director | 2023-09-29 | SELL | 25,000 | $12.41 | $310.3K |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | 2023-09-19 | SELL | 20,000 | $12.67 | $253.4K |
| BIOTECHNOLOGY VALUE FUND L P | 2023-09-12 | BUY | 1,505,932 | $9.84 | $14818.4K | |
| Harmon Cyrus | Director | 2023-09-05 | SELL | 25,000 | $10.26 | $256.5K |
| Harmon Cyrus | Director | 2023-08-16 | SELL | 15,000 | $10.14 | $152.1K |
| Harmon Cyrus | Director | 2023-08-16 | SELL | 15,000 | $10.14 | $152.1K |
| Harmon Cyrus | Director | 2023-06-08 | SELL | 10,000 | $6.3 | $63K |
| Harmon Cyrus | Director | 2023-06-06 | SELL | 10,000 | $6.17 | $61.7K |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | 2023-04-06 | BUY | 10,000 | $3.29 | $32.9K |
| BIOTECHNOLOGY VALUE FUND L P | 2022-06-10 | BUY | 200,000 | $4.03 | $806K | |
| Horn Kinney | CHIEF BUSINESS OFFICER | 2022-01-10 | SELL | 5,251 | $6.85 | $36K |
| Horn Kinney | CHIEF BUSINESS OFFICER | 2021-12-10 | SELL | 5,251 | $10.39 | $54.6K |
| Myles David C. | CHIEF DEVELOPMENT OFFICER | 2021-12-10 | SELL | 10,000 | $10.3 | $103K |
| BIOTECHNOLOGY VALUE FUND L P | 2021-11-30 | BUY | 739,675 | $9.39 | $6945.5K | |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | 2021-11-29 | SELL | 400 | $24.76 | $9.9K |
| Horn Kinney | CHIEF BUSINESS OFFICER | 2021-11-10 | SELL | 27,668 | $26.88 | $743.7K |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | 2021-10-19 | SELL | 12,000 | $27.98 | $335.8K |
| Bohen Sean | PRESIDENT AND CEO | 2021-10-14 | SELL | 5,000 | $30.47 | $152.4K |
| Horn Kinney | CHIEF BUSINESS OFFICER | 2021-10-11 | SELL | 5,251 | $27.9 | $146.5K |
| Bohen Sean | PRESIDENT AND CEO | 2021-09-27 | SELL | 1,085 | $30.07 | $32.6K |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | 2021-09-20 | SELL | 12,000 | $26.3 | $315.6K |
| Horn Kinney | CHIEF BUSINESS OFFICER | 2021-09-10 | SELL | 5,251 | $29.38 | $154.3K |
| Bohen Sean | PRESIDENT AND CEO | 2021-09-08 | SELL | 3,044 | $30.01 | $91.4K |
| Bohen Sean | PRESIDENT AND CEO | 2021-09-01 | SELL | 871 | $30.05 | $26.2K |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | 2021-08-19 | SELL | 12,000 | $24.97 | $299.6K |
| Horn Kinney | CHIEF BUSINESS OFFICER | 2021-08-10 | SELL | 5,251 | $25.71 | $135K |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | 2021-07-20 | SELL | 12,000 | $25.1 | $301.2K |
| Horn Kinney | CHIEF BUSINESS OFFICER | 2021-07-12 | SELL | 5,251 | $26.51 | $139.2K |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | 2021-06-18 | SELL | 12,000 | $24.8 | $297.6K |
| Horn Kinney | CHIEF BUSINESS OFFICER | 2021-06-10 | SELL | 5,251 | $29.72 | $156.1K |
| Horn Kinney | CHIEF BUSINESS OFFICER | 2021-05-18 | SELL | 57,763 | $24.15 | $1395K |
| Graham G. Walmsley | Director | 2020-11-23 | BUY | 1,160,000 | $19 | $22040K |
| Cormorant Asset Management, LP | 2020-11-23 | BUY | 425,000 | $19 | $8075K | |
| BIOTECHNOLOGY VALUE FUND L P | 2020-11-19 | BUY | 1,135,334 | $19 | $21571.3K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked